Medicure (MCUJF) Return on Capital Employed (2009 - 2026)
Medicure (MCUJF) posted quarterly Return on Capital Employed of 13.71% for Q1 2026, up 3074.0% year-over-year from 0.43% in Q1 2025, and up 645.07% quarter-over-quarter from 2.52% in Q4 2025.
Medicure (MCUJF) Return on Capital Employed (2009 - 2026) Analysis & Trends
Medicure's Return on Capital Employed history runs 18 years deep, the most recent figure standing at 13.71% for Q1 2026.
- In Q1 2026, Return on Capital Employed rose 3074.0% year-over-year to 13.71%; the TTM figure through Mar 2026 stood at 13.71% (up 3074.0% YoY), while the FY2025 annual figure was 43.04%, down 2980.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 13.71%, up from 2.52% in the prior quarter.
- The five-year high for Return on Capital Employed was 51.52% in Q1 2023, with the low at 17.03% in Q1 2025.
- The 5-year median for Return on Capital Employed is 4.2% (2024), against an average of 6.85%.
- The sharpest annual moves came in 2023 and 2024: Return on Capital Employed jumped 4635 bps in 2023, then tumbled 4732 bps in 2024.
- Medicure's Return on Capital Employed stood at 39.06% in 2022, then fell by 25 bps to 29.34% in 2023, then slumped by 145 bps to 13.25% in 2024, then jumped by 81 bps to 2.52% in 2025, then surged by 645 bps to 13.71% in 2026.
- Business Quant data shows MCUJF's Return on Capital Employed at 13.71% in Q1 2026, 2.52% in Q4 2025, and 4.99% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.27 Bn | 43.31 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.64 Bn | 39.99 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.26 Bn | 30.58 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 22.29 Bn | 19.62 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.86 Bn | 17.98 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 11.96 Bn | 11.43 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Medicure | 96.01 Mn | 94.89 Mn | 2.57 Mn | 29.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.71% |
| Dec 31, 2025 | -2.52% |
| Sep 30, 2025 | -4.99% |
| Jun 30, 2025 | -15.73% |
| Mar 31, 2025 | -17.03% |
| Dec 31, 2024 | -13.25% |
| Sep 30, 2024 | -9.01% |
| Jun 30, 2024 | -2.92% |
| Mar 31, 2024 | 4.20% |
| Dec 31, 2023 | 29.34% |
| Mar 31, 2023 | 51.52% |
| Dec 31, 2022 | 39.06% |
| Sep 30, 2022 | 15.27% |
| Jun 30, 2022 | 9.89% |
| Mar 31, 2022 | 5.16% |
| Dec 31, 2021 | 2.50% |
| Sep 30, 2021 | -20.55% |
| Jun 30, 2021 | -20.46% |
| Mar 31, 2021 | -26.21% |
| Dec 31, 2020 | -35.79% |